Merz files patent infringement case against two international pharmaceutical companies
Merz is taking two Indian and Israeli pharmaceutical companies to court for patent infringement of their chronic drooling treatment. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 14, 2018 Category: Pharmaceuticals Authors: Seth Gulledge Source Type: news

World ’s first lab-grown steak revealed – but the taste needs work
Nascent industry aims to reduce environmental impact of beef productionThe first steak grown from cells in the lab and not requiring the slaughter of a cow has been produced in Israel.The meat is not the finished article: the prototype costs $50 for a small strip, and the taste needs perfecting, according to its makers. But it is the first meat grown outside an animal that has a muscle-like texture similar to conventional meat.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 14, 2018 Category: Science Authors: Damian Carrington Environment editor Tags: The meat industry Food Food science Beef Environment Israel World news Farming Middle East and North Africa Source Type: news

Colorectal Cancer Screening Pill to Be in US Pilot Study
Check-Cap is getting one step closer to having its capsule-based screening method for colorectal cancer on the U.S. market. The Isfiya, Israel-based company has received FDA conditional approval for an IDE to initiate a pilot study of the C-Scan capsule. FDA’s conditional approval of the IDE requires Check-Cap to provide additional information to the agency and the company may begin enrolling patients immediately upon approval by the study site's Institutional Review Board (IRB). The trial will consist of up to 45 patients and it will be a single-arm study. Patients who are enrolled will be those conside...
Source: MDDI - December 13, 2018 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Implants Source Type: news

Check-Cap wins conditional IDE approval for C-Scan pilot study
Check-Cap (NSDQ:CHEK) said today it won conditional approval from the FDA for its investigational device exemption application to launch a pilot study of its C-Scan system. The Israel-based company’s C-Scan system is designed as an alternative to standard colon cancer screening methods. The system uses an ingestible, ultra-low dose X-ray capsule and a wireless tracking system to return structural information on the lumen of the colon to create 2D and 3D maps. The conditional approval will require Check-Cap to provide additional information to the FDA, but will allow the company to being enrolling patients immedi...
Source: Mass Device - December 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Diagnostics Food & Drug Administration (FDA) Check-Cap Source Type: news

Lehigh's Israel E. Wachs elected Fellow of National Academy of Inventors (NAI)
(Lehigh University) Dr. Israel E. Wachs, the G. Whitney Snyder Professor of Chemical and Biomolecular Engineering at Lehigh University's P.C. Rossin College of Engineering and Applied Science has been elected as a fellow of the National Academy of Inventors (NAI). Wachs has earned worldwide recognition for his heterogeneous catalysis research and for his modern approach to establishing fundamental relationships between surface structure and kinetic activity for metal oxides catalysts. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 13, 2018 Category: Biology Source Type: news

Israel Likely to Allow Medical Cannabis Exports by Year-End - Senior MP Israel Likely to Allow Medical Cannabis Exports by Year-End - Senior MP
Israel will likely allow exports of medical cannabis by the end of the year, a top lawmaker said on Thursday, a move that would boost state coffers and slow the growing number of firms establishing farms abroad.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 12, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Study evaluates efficacy and safety of pancreatic cancer treatment
(Beth Israel Deaconess Medical Center) In a new study published in the Journal of Clinical Oncology, Manuel Hidalgo, MD, PhD, and colleagues conducted a phase I/II trial designed to evaluate the efficacy and safety of nab-paclitaxel given in combination with gemcitabine in patients with pancreatic cancer and reduced health status. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 12, 2018 Category: Cancer & Oncology Source Type: news

Loss of tight junction protein promotes development of precancerous cells
(Beth Israel Deaconess Medical Center) BIDMC researchers demonstrated that the lack of claudin 18 prompted the development of precancerous, abnormal cells and polyps in the engineered mouse model. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 12, 2018 Category: Cancer & Oncology Source Type: news

WhiteSwell Develops a Different Way to Treat Heart Failure
A small medtech company is looking at tackling a huge problem in one of the toughest markets to navigate in healthcare. Galway, Ireland-based WhiteSwell has set its sights on developing a minimally invasive catheter approach that can drain the excess fluid that can be found in acute decompensated heart failure (ADHF) patients. But WhiteSwell isn’t going into this endeavor unprepared or without support. The small medtech company said it has just raised $30 million in a round led by RA Capital Management and an InCube Ventures syndicate, with participation from other investors. “The $30 mi...
Source: MDDI - December 11, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Large Companies Eye Collaboration as Entry into AI
Edwards Lifesciences is delving deeper into the realm of artificial intelligence through a partnership with San Francisco-based Bay Labs. The goal of the collaboration, which has multiple initiatives is to improve the detection of heart disease. Some of the initiatives include, the development of new AI-powered algorithms in Bay Labs’ EchoMD measurement and interpretation software suite; support for ongoing clinical studies at institutions; and the integration of EchoMD algorithms into Edwards Lifesciences’ CardioCare quality care navigation platform. Irvine, CA-based Edwardsâ€...
Source: MDDI - December 10, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Israel Likely to Allow Medical Cannabis Exports by Year-End - Senior MP Israel Likely to Allow Medical Cannabis Exports by Year-End - Senior MP
Israel will likely allow exports of medical cannabis by the end of the year, a top lawmaker said on Thursday, a move that would boost state coffers and slow the growing number of firms establishing farms abroad.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 9, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Partners ready to take on BI Lahey competition after strong fiscal year
Partners HealthCare is wrapping up fiscal 2018 with its highest operating margin in six years, and says it's ready to take on whatever competition may come from the combined Beth Israel Lahey Health. The state’s largest health system on Friday reported a $310 million operating income on $13.3 billion in revenue, or a 2.3 percent operating margin. That compares to $52.6 million in operating income on $13.4 billion in revenue for fiscal 2017, or a 0.4 percent operating margin. Partners hasn’ t… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 7, 2018 Category: Biotechnology Authors: Jessica Bartlett Source Type: news

Generic Drugmaker to Sell Alternative to EpiPen Injectors
TRENTON, N.J. (AP) — Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year. The EpiPen injector is used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems. Sandoz will sell prefilled syringes with the same medicine, the hormone epinephrine, under the name Symjepi. The price will be $250 for two, without insurance. Two generic versions of EpiPen are sold in the U.S. for $300 a pair, including one from Ep...
Source: JEMS Patient Care - December 7, 2018 Category: Emergency Medicine Authors: Linda A. Johnson, AP Medical Writer Tags: Patient Care News Source Type: news

Generic Drugmaker to Sell Alternative to EpiPen Injectors
TRENTON, N.J. (AP) — Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year. The EpiPen injector is used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems. Sandoz will sell prefilled syringes with the same medicine, the hormone epinephrine, under the name Symjepi. The price will be $250 for two, without insurance. Two generic versions of EpiPen are sold in the U.S. for $300 a pair, including one from Ep...
Source: JEMS: Journal of Emergency Medical Services News - December 7, 2018 Category: Emergency Medicine Authors: Linda A. Johnson, AP Medical Writer Tags: Patient Care News Source Type: news

Generic Drugmaker To Sell Cheaper Alternative To EpiPen Injectors
TRENTON, N.J. (AP) — Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year. The EpiPen injector is used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems. Sandoz will sell prefilled syringes with the same medicine, the hormone epinephrine, under the name Symjepi. The price will be $250 for two, without insurance. Two generic versions of EpiPen are sold in the U.S. for $300 a pair, including one from Ep...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 7, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News EpiPen Local TV Source Type: news

Profiling a killer in warm blood
(Weizmann Institute of Science) Israeli scientists and physicians develop a new technology for profiling the unique genetic makeup of myeloma tumor cells that will allow better diagnosis and treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

PolyU jointly organizes the University Social Responsibility Summit 2018
(The Hong Kong Polytechnic University) The Hong Kong Polytechnic University (PolyU) co-hosted the University Social Responsibility (USR) Summit 2018 in Haifa, Israel, with University of Haifa and The Hebrew University of Jerusalem in early December this year. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 5, 2018 Category: International Medicine & Public Health Source Type: news

Genetic and environmental contributions to children's prosocial behavior: brief review and new evidence from a reanalysis of experimental twin data - Knafo-Noam A, Vertsberger D, Israel S.
Children's prosocial behaviors show considerable variability. Here we discuss the genetic and environmental contributions to individual differences in children's prosocial behavior. Twin research systematically shows, at least from the age of 3 years, a ge... (Source: SafetyLit)
Source: SafetyLit - December 5, 2018 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Here ’s One Simple Way You Can Start Eating Healthier
People are drinking less soda than they used to. But in nearly every other way, the typical American diet hasn’t improved in a very long time. “If you look at how we’re eating—the quality of our diets—it’s been pretty constant over a number of decades,” says Dr. Stephen Juraschek, an internist at Beth Israel Deaconess Medical Center and an instructor of medicine at Harvard Medical School. Americans still eat too much red meat, too many refined grains and too much protein. “The average American already consumes more than enough protein, but people are still seeking out more,&r...
Source: TIME: Health - December 4, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Diet/Nutrition Source Type: news

Former BIDMC exec resigns as president from Tampa hospital
A former Boston hospital executive has resigned as president of St. Joseph's Children's and Women's hospitals in Tampa after just a year and half.   Kate Reed resigned last week, a spokeswoman for BayCare Health System, the hospitals' parent company, confirmed Monday. Reed previously had served as senior vice president and chief strategy officer for Beth Israel Deaconess Medical Center in Boston.  The spokeswoman said a search is under w ay to replace both Reed and Matt Novak, former president… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 4, 2018 Category: Pharmaceuticals Authors: Ashley Gurbal Kritzer Source Type: news

Medtronic eyes more investment in Israel
Medtronic‘s (NYSE:MDT) chief executive Omar Ishrak traveled to Israel on Sunday with a team of senior executives to reportedly meet with some of the firms that the medtech giant has recently acquired, including Mazor Robotics and Nutrino. Ishrak is also scheduled to meet with Israel’s prime minister Benjamin Netanyahu and Eli Cohen, the minister of economy and industry. Also on this week’s trip, Medtronic reportedly signed a deal with the Israel Innovation Authority to support a new center focused on research and development. The company has long signaled interest in the Israeli medtech arena and thi...
Source: Mass Device - December 3, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured Wall Street Beat mazorrobotics Medtronic nutrinohealth Source Type: news

RedHill Biopharma's antibiotic succeeds in late-stage study
Israel-based RedHill Biopharma Ltd said on Monday its combination antibiotic met the main goal of a late-stage study testing the drug in patients with a type of bacterial infection that affects the stomach and small intestine. (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Benefits of CBD Liquid for Epilepsy May Fade With Time: Study
SUNDAY, Dec. 2, 2018 -- A marijuana-derived drug that helps control epileptic seizures appears to become less effective over time in some patients, a new Israeli study reports. Cannabidiol (CBD) liquid has been proven effective against seizures, but... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 2, 2018 Category: General Medicine Source Type: news

EZbra: Why Didn & #039;t Anyone Think of This Before?
Efrat Roman was diagnosed with breast cancer a little more than a decade ago and underwent a total of five different surgeries due to complications. As if going through multiple breast operations weren't challenging enough, Roman was surprised to find out that the post-op breast dressing options were severely lacking. "I realized there wasn't anything designated for the dressing of breasts post-op," Roman told MD+DI. "There are reusable bras that are post-op bras, but the fact that they are reusable is not enough because many breast cancer patients will suffer from some kind of asymmetry and with the reusabl...
Source: MDDI - November 30, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Meet the Post-Op Bra That & #039;s Long Overdue
Efrat Roman was diagnosed with breast cancer a little more than a decade ago and underwent a total of five different surgeries due to complications. As if going through multiple breast operations weren't challenging enough, Roman was surprised to find out that the post-op breast dressing options were severely lacking. "I realized there wasn't anything designated for the dressing of breasts post-op," Roman told MD+DI. "There are reusable bras that are post-op bras, but the fact that they are reusable is not enough because many breast cancer patients will suffer from some kind of asymmetry and with the reusabl...
Source: MDDI - November 30, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Economists are skeptical of AG's limits on Beth Israel, Lahey hospital merger
Some health care economists say the agreement ’s main provision — the price caps — doesn't do enough to prevent an anti-competitive health care market from emerging. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 30, 2018 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

Blog: Our union stands against cruel and callous actions of the Israeli government
Everyone deserves the right to be treated with dignity and fairness, protected from violence and fear. Our children deserve that most of all. These rights are enshrined in the UN convention on the rights of the child, which celebrated its 29th anniversary last week. Yet for too many Palestinian children, those rights have been taken from them by the cruel and callous actions of the Israeli government. This morning I was at 10 Downing Street, standing alongside friends from the Palestine Solidarity Campaign, to demand that Theresa May take action to end to the mistreatment of Palestinian children under Israeli military dete...
Source: UNISON Health care news - November 29, 2018 Category: UK Health Authors: Dave Prentis Tags: General secretary's blog News international Palestine Source Type: news

Deb Henretta named to Nuvo Group Ltd. board
Former Procter& Gamble Co. executive Deb Henretta has been named to the board of Nuvo Group Ltd., which is developing a sensor-based wearable device to help parents monitor the health of a baby during pregnancy. Henretta, 56, had been group president of global e-business for the Cincinnati-based maker of consumer goods such as Pampers diapers (NYSE: PG) and before that group president of P&G ’s $20 billion Global Beauty division. Israel-based Nuvo Group’s initial product offering for health… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 28, 2018 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news

Health Highlights: Nov. 28, 2018
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Salmonella Outbreak Linked to Tahini Imported from Israel: FDA A multistate salmonella outbreak has been linked to tahini imported from Israeli... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 28, 2018 Category: General Medicine Source Type: news

Teva matches Mylan EpiPen generic price
The Israeli drugmaker is launching its generic EpiPen at the wholesale price of $300 for a pack of two auto-injectors (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 27, 2018 Category: Pharmaceuticals Source Type: news

Aidoc partners with Nuance on AI validation process
Israeli artificial intelligence (AI) software developer Aidoc has partnered...Read more on AuntMinnie.comRelated Reading: Aidoc partners with SaferMD on AI for MIPS reporting Aidoc adds U.S., European sales directors Aidoc lands FDA clearance for AI software in head CT Aidoc unveils AI algorithm for analysis of CT scans Aidoc Medical raises $7M (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 27, 2018 Category: Radiology Source Type: news

Achdut Recalls Multiple Brands of " Tahini " Because It May Be Contaminated with Salmonella
Achdut LTD. of Ariel, Israel, is recalling its Tahini products of all packages and sizes produced on the following dates: April 7th to May 21st 2018, because it may be contaminated withSalmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 27, 2018 Category: Food Science Source Type: news

Achdut Recalls Multiple Brands of " Tahini " Because It May Be Contaminated with < em > Salmonella < /em > Clarification for Baron's Expiration Date
Achdut LTD. of Ariel, Israel, is recalling its Tahini products of all packages and sizes produced on the following dates: April 7th to May 21st 2018, because it may be contaminated withSalmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 27, 2018 Category: Food Science Source Type: news

Another EpiPen Is Now on the Market
Teva Pharmaceuticals has finally launched its generic version of Mylan’s EpiPen.  The Petah, Tikvah, Israel-based company’s emergency allergy shot will be priced at $300 – the same as Mylan’s generic. Teva received approval for its version of EpiPen in August. The generic will be available in limited supply and the company will launch a lower-dose - the EpiPen Jr. sometime next year, the company said. “We’re pleased to provide access to Epinephrine Injection (Auto-Injector) for patients who may experience...
Source: MDDI - November 27, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Startups defy gravity to explore space's commercial frontiers
Small firms spot an opportunity in emerging industry of microgravity experimentationIn a cramped office hidden within the poorly lit corridors of a shopping mall in Israel, sits the equivalent of Nasa ’s mission control in Houston.Yet there are no rows of scientists and flight controllers wearing headsets, all of their faces fixed on a large screen charting spacecraft. And no astronauts telling them they have a problem.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 27, 2018 Category: Science Authors: Oliver Holmes in Herzliya, Israel Tags: Space Science Israel Middle East and North Africa US news World news Source Type: news

Medtronic Eyes Familiar Face in New Acquisition
Medtronic is acquiring, Nutrino, a company that uses artificial intelligence for nutrition-related services. The medtech giant will pick up the Tel Aviv, Israel based company for an undisclosed amount. The acquisition is expected to close in Medtronic’s third fiscal quarter ending in January 25, 2019. By bringing Nutrino in the fold, Medtronic can help strengthen its presence in the diabetes management market. And it’s not like the two companies are strangers. Nutrino played a role in recent U.S. product introductions from Medtronic, including the updated iPro2 myLog app used with profes...
Source: MDDI - November 26, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

Israeli Company Set To Begin Testing New Radiation Cancer Therapy
An Israeli medical technology company is set to begin testing a new radiation cancer therapy, that kills cancer cells while sparing surrounding tissue, in leading medical centers in Italy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 26, 2018 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news

Party people and party identification: a theory of youth independence and political opinions - Goldstein KL, Shem-Tov OY.
Unsupervised, early adulthood behaviours affect young people's preference for a political party. Quantitative analysis was conducted on a nationally representative survey with high school students in Israel. Data were collected following the 2009 legislati... (Source: SafetyLit)
Source: SafetyLit - November 26, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Breast cancers enhance their growth by recruiting cells from bone marrow
(Rockefeller University Press) Researchers in Israel have discovered that breast tumors can boost their growth by recruiting stromal cells originally formed in the bone marrow. The study, which will be published Nov. 23 in the Journal of Experimental Medicine, reveals that the recruitment of bone marrow-derived fibroblasts lowers the odds of surviving breast cancer, but suggests that targeting these cells could be an effective way of treating the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 23, 2018 Category: Cancer & Oncology Source Type: news

Teen obesity tied to increased risk of pancreatic cancer
(Reuters Health) - Teen obesity has been linked with many health problems later in life, and a large Israeli study suggests increased risk for deadly pancreatic cancer is one of them. (Source: Reuters: Health)
Source: Reuters: Health - November 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

E-Motion Medical wins CE Mark for acute digestive dysmotility stimulator
E-Motion Medical said yesterday that it won CE Mark approval in the European Union for its E-Motion stimulation therapy system intended to treat patients with acute gastrointestinal dysmotility. The Israel-based company said that the E-Motion system is designed to deliver “unique patterns” of electrical stimulation to the esophagus using its E-Motion tube, which is placed in the same manner as a regular feeding tube. Stimulation from the newly cleared system generates contractions in the esophagus to restore natural function to the digestive system and to promote motility through the gastrointestinal tract, E-M...
Source: Mass Device - November 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Otolaryngology Ear, Nose & Throat Regulatory/Compliance emotionmedical Source Type: news

Zebra, Clalit Health tout research at RSNA 2018
Artificial intelligence software developer Zebra Medical Vision and Israeli...Read more on AuntMinnie.comRelated Reading: FDA clears Zebra Medical's CAC scoring software Zebra Medical secures $30M in financing Zebra, Change Healthcare partner on AI Zebra to exhibit AI image analysis with Google at RSNA 2017 Zebra Medical, Clalit Health complete bone density algorithm (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 20, 2018 Category: Radiology Source Type: news

Here ’s What Eating a Thanksgiving Feast Actually Does to Your Body
Thanksgiving is a time for gratitude, good-will and gluttony. While many people enjoy the holiday feast with abandon, some dieters and healthy eaters stress over the idea of consuming a huge number of calories in one sitting. But is it worth the worry? Here’s what eating one enormous meal actually does to your body, according to experts. The short-term effects of a big meal When you consume lots of food, your stomach has to physically expand to accommodate the additional volume, potentially leading to some discomfort, says Dr. Stephen Juraschek, an internist and primary care physician at Beth Israel Deaconess Medical...
Source: TIME: Health - November 20, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Diet/Nutrition Holidays 2018 Source Type: news

Mazor Robotics shareholders OK $1.6B Medtronic merger
Mazor Robotics (NSDQ:MZOR) said that its shareholders yesterday approved the $1.6 billion merger with Medtronic (NYSE:MDT). The Caesarea, Israel-based company said roughly 53% of its shares were represented in the vote, with about 95% of those cast in favor of the $58.50-per-ADR-share deal. The world’s largest medical device maker has held a position in Mazor, which makes the Mazor X guidance system and the Renaissance robot-assisted spine surgery platform, since May 2016. In September they closed the third, $40 million tranche of that investment, giving Medtronic a 10.6% stake...
Source: Mass Device - November 20, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Robotics Wall Street Beat mazorrobotics Medtronic Source Type: news

E-Motion Medical Receives CE Mark Approval for Its Novel Stimulation Therapy for Patients With Acute Digestive Dysmotility
TEL AVIV, Israel, Nov. 20, 2018 -- (Healthcare Sales & Marketing Network) -- E-Motion Medical Ltd. announced today it has received CE Mark approval for its lead product, the E-Motion System™, providing stimulation therapy that restores the natural motor f... Devices, Gastroenterology, Regulatory E-Motion Medical, E-Motion System, E-Motion Tube, gastrointestinal dysmotility (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2018 Category: Pharmaceuticals Source Type: news

Aidoc partners with SaferMD on AI for MIPS reporting
Israeli artificial intelligence (AI) software developer Aidoc and SaferMD have...Read more on AuntMinnie.comRelated Reading: Aidoc adds U.S., European sales directors Aidoc lands FDA clearance for AI software in head CT Aidoc unveils AI algorithm for analysis of CT scans SaferMD helps radiologists reduce malpractice risk Brit teams with SaferMD (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 19, 2018 Category: Radiology Source Type: news

Medical College's McCrea joins $14.7M concussion study funded by NFL
Medical College of Wisconsin professor Michael McCrea is a co-principal investigator in a $14.7 million, five-year study on potential long-term neurologic health consequences of concussions and sub-concussive injuries sustained by former NFL players. The grant from the NFL went to Boston Children’s Hospital and will be split among the other co-principal investigators: the Medical College of Wisconsin in Wauwatosa; Beth Israel Deaconess Medical Center in Boston; and the University of North Carolina… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 19, 2018 Category: Pharmaceuticals Authors: Rich Kirchen Source Type: news

Delegates discuss international concerns
In one of a series of debates on international issues at UNISON’s LGBT conference in Harrogate, Bernie McGuire from the West Midlands highlighted the issue of Palestine and how support for the actions of the Israeli state is coming from “reactionary” regimes. For the national committee, Jackie Lewis pointed out that, on the 14 May, as Israel and the US celebrated the opening of the new US embassy in Jerusalem, unarmed protestors against the illegal, 11-year blockade of Gaza were being shot at and killed. She warned against pinkwashing – attempts by the Israeli state to portray itself as a liberal so...
Source: UNISON meat hygiene - November 17, 2018 Category: Food Science Authors: Amanda Kendal Tags: Article News 2018 LGBT Conference colombia international Israel jamaica LGBT members Palestine Turkey Source Type: news

Emergency with resiliency equals efficiency - challenges of an EMT-3 in Nepal - Yitzhak A, Merin O, Halevy J, Tarif B.
The 7.8 MW (moment magnitude scale) earthquake that hit Nepal on April 25, 2015 caused significant casualties and serious damage to infrastructure.The Israeli Emergency Medical Team (IEMT; later verified as EMT-3) was deployed 80 hours after the earthquake... (Source: SafetyLit)
Source: SafetyLit - November 17, 2018 Category: International Medicine & Public Health Tags: Disaster Preparedness Source Type: news